Interaction Between Domperidone and Ketoconazole: Toward Prediction of Consequent QTc Prolongation Using Purely In Vitro Information-Reference-Cited by-同舟云学术

Interaction Between Domperidone and Ketoconazole: Toward Prediction of Consequent QTc Prolongation Using Purely In Vitro Information

Published:2014-08 Issue:8 Volume:3 Page:130
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT: Pharmacometrics & Systems Pharmacology

Author:

Mishra H¹,Polak S¹²,Jamei M¹,Rostami-Hodjegan A¹³

Affiliation:

1. Simcyp Limited (a Certara Company), Blades Enterprise Centre; Sheffield UK

2. Unit of Pharmacoepidemiology and Pharmacoeconomics, Faculty of Pharmacy; Jagiellonian University Medical College; Krakow Poland

3. Manchester Pharmacy School, University of Manchester; Manchester UK

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/psp.2014.26/fullpdf

Reference51 articles.

1. Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative;Piccini;Am. Heart J.,2009

2. International Conference on Harmonisation. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrythmic drugs http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Guideline.pdf

3. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation;Piotrovsky;AAPS J.,2005

4. Multiscale modelling of drug-induced effects on cardiac electrophysiological activity;Brennan;Eur. J. Pharm. Sci.,2009

5. Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?;Towart;J. Pharmacol. Toxicol. Methods,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond homogeneity: Assessing the validity of the Michaelis–Menten rate law in spatially heterogeneous environments;PLOS Computational Biology;2024-06-06

2. On the Verge of Impossibility: Accounting for Variability Arising from Permutations of Comorbidities that Affect the Fate of Drugs in the Human Body;AAPS Introductions in the Pharmaceutical Sciences;2023

3. Case Study on Certara’s Simcyp PBPK Simulator to Eliminate Lengthy Clinical Trails;International Journal of Health Sciences and Pharmacy;2022-10-12

4. Simultaneous Ivabradine Parent-Metabolite PBPK/PD Modelling Using a Bayesian Estimation Method;The AAPS Journal;2020-10-08

5. Beyond the Michaelis‐Menten: Accurate Prediction ofIn VivoHepatic Clearance for Drugs With LowKM;Clinical and Translational Science;2020-05-26